10481-0112 : Monsels Solution .21 g/g Topical Liquid


NDC10481-0112
Labeler: Gordon Laboratories
Product Type: Human Prescription Drug
Drug Name: Monsels Solution
Dosage Form: Topical Liquid
Rev. Date: 


NDC Package Codes:

  • 10481-0112-2: 59 G IN 1 BOTTLE, GLASS (10481‑0112‑2)
  • 10481-0112-8: 8 G IN 1 BOTTLE, GLASS (10481‑0112‑8)

Active Ingredients:

  • Ferric Subsulfate

Dosage Strength:

  • .21 g/g

Related Products:

Based on records with the same trade name.
  • 42721-112 Monsels Solution 20 g/100g Topical Liquid by Biodiagnostic International
  • 48783-112 Monsels Solution 210 mg/g Topical Paste by Premier Dental Products Company
  • 48992-001 Monsels Solution 210 mg/g Topical Paste by Gynex Corporation
  • 70880-112 Monsels Solution 20 g/100ml Topical Solution by Medgyn Products, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 10481-0112 QR Code

< Prev: 10481-0111Next: 10481-1050 >

Related Discussions:

FERRIC OXIDE RED in Brn Verapamil from Glen vs Bl from Mylan
I have been taking the Blue oblong tab 180mg from Mylan, I think, for years with no problem (for chronic migraine relief... 1 reply
ferric yellow oxide
I am allergic to the aluminum lake red and yellow colors (all of them). How do ferric colors differ from aluminum lake c... 1 reply
Preservative ferric oxide
Very hard to find inactive ingredients listed on generic meds. Very allergic, hives swelling of face and tongue. Pharmac... 1 reply
Possible side effects for ferric carboxymaltose
I recently had an infusion of 500mil of diluted ferric carboxymaltose 13 days ago. Since then I have experienced sever f... 5 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.